Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 3/20 | 0.77 |
| ▸ | HTR2A | P28223 | 11/20 | 0.67 |
| ▸ | HTR2C | P28335 | 7/20 | 0.67 |
| ▸ | HTR2B | P41595 | 7/20 | 0.67 |
| ▸ | HTR1A | P08908 | 5/20 | 0.67 |
| ▸ | DRD1 | P21728 | 1/20 | 0.63 |
| ▸ | HTR1D | P28221 | 1/20 | 0.63 |
| ▸ | HTR1B | P28222 | 1/20 | 0.63 |
| ▸ | HTR1E | P28566 | 1/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.63 |
| ▸ | HTR7 | P34969 | 1/20 | 0.63 |
| ▸ | DRD3 | P35462 | 1/20 | 0.63 |
| ▸ | HTR5A | P47898 | 1/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | HTR1F | P30939 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | MPO | P05164 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29993252 | 0.87 | HTR6 (1.00) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL29758535 | 0.87 | HTR6 (1.00) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL19235737 | 0.87 | HTR6 (1.00) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| Hydrochloric Acid SCHEMBL4208783 | 0.86 | HTR6 (0.97) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL24723621 | 0.83 | HTR6 (0.73) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL30681600 | 0.83 | HTR6 (0.73) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL29992491 | 0.83 | HTR6 (0.82) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074609 | 0.83 | HTR6 (0.73) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074608 | 0.82 | HTR6 (0.71) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL3183303 | 0.82 | HTR6 (0.71) | HTR6HTR2AHTR2CHTR2BHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20240366638-A1 | PSILOCYBIN ANALOGS FOR TREATING PSYCHOLOGICAL DISORDERS | SYNAPTIVE THERAPEUTICS, LLC | 2024-11-07 | — | — | US | disclosed |
| US-20230405026-A1 | A Method of Treating Depression by Immune Modulation | MYND LIFE SCIENCES INC (CA) | 2023-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366638-A1 | PSILOCYBIN ANALOGS FOR TREATING PSYCHOLOGICAL DISORDERS | HTR1B, HTR2B, PNMT | HTR6 12/4885HTR2A 5/4885HTR2C 4/4885 |
| US-20230405026-A1 | A Method of Treating Depression by Immune Modulation | ABCF1, ABCF2, ABCB4 | HTR6 549/4885HTR2A 377/4885HTR2C 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.